Satellos Bioscience Inc (MSCL)

Currency in CAD
0.5700
0.0000(0.00%)
Closed·
MSCL Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
MSCL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.57000.6200
52 wk Range
0.45001.3200
Key Statistics
Bid/Ask
0.57 / 0.59
Prev. Close
0.57
Open
0.59
Day's Range
0.57-0.62
52 wk Range
0.45-1.32
Volume
205.27K
Average Volume (3m)
153.57K
1-Year Change
20%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MSCL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
1.2250
Upside
+114.91%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Satellos Bioscience Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Satellos Bioscience Inc Company Profile

Satellos Bioscience Inc., a biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia. The company uses its proprietary platform MyoReGenX, an automated microscopy system that recapitulates the muscle stem cell environment ex-vivo. It develops SAT-3247 an oral, small-molecule drug candidate for the treatment of Duchenne muscular dystrophy disease. The company has a license agreement the with Ottawa Hospital Research Institute (OHRI); and an option agreement with the University of British Columbia. Satellos Bioscience Inc. was founded in 2018 and is headquartered in Toronto, Canada.

Compare MSCL to Peers and Sector

Metrics to compare
MSCL
Peers
Sector
Relationship
P/E Ratio
−3.6x−2.1x−0.5x
PEG Ratio
0.510.000.00
Price/Book
1.8x−0.1x2.6x
Price / LTM Sales
-5.6x3.3x
Upside (Analyst Target)
114.9%205.7%43.5%
Fair Value Upside
Unlock7.2%6.8%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 1.2250
(+114.91% Upside)

Earnings

Latest Release
May 13, 2025
EPS / Forecast
-0.0559 / -0.0367
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

MSCL Income Statement

FAQ

What Stock Exchange Does Satellos Bioscience Trade On?

Satellos Bioscience is listed and trades on the Toronto Stock Exchange stock exchange.

What Is the Stock Symbol for Satellos Bioscience?

The stock symbol for Satellos Bioscience is "MSCL."

What Is the Satellos Bioscience Market Cap?

As of today, Satellos Bioscience market cap is 100.49M.

What Is Satellos Bioscience's Earnings Per Share (TTM)?

The Satellos Bioscience EPS (TTM) is -0.23.

When Is the Next Satellos Bioscience Earnings Date?

Satellos Bioscience will release its next earnings report on 31 Aug 2025.

From a Technical Analysis Perspective, Is MSCL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Satellos Bioscience Stock Split?

Satellos Bioscience has split 2 times.

How Many Employees Does Satellos Bioscience Have?

Satellos Bioscience has 16 employees.

What is the current trading status of Satellos Bioscience (MSCL)?

As of 09 Aug 2025, Satellos Bioscience (MSCL) is trading at a price of 0.57, with a previous close of 0.57. The stock has fluctuated within a day range of 0.57 to 0.62, while its 52-week range spans from 0.45 to 1.32.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.